EGFR and lung carcinoma: Therefore, to reduce the fraction of misclassified samples, it was recently proposed in the evidence-based guideline of three professional societies (College of American Pathologists, International Associations for the Study of Lung Cancer, and Association for Molecular Pathology) that, if possible, EGFR mutation testing should be carried out with two methods (a two-tiered testing strategy).